The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > NeoTherapeutics, Inc.

NeoTherapeutics, Inc.
Nasdaq: NEOT
Change
symbol:
     
 PROFILE
NeoTherapeutics doesn't want you to be a degenerate. The firm develops drugs to treat degenerative conditions of the central nervous system. The company's technology is based on tiny synthetic molecules that encourage nerve cells to regrow and prevent degeneration. NeoTherapeutic is developing lead drug candidate Neotrofin as a treatment for Alzheimer's disease, Parkinson's disease, and spinal cord injuries. The company also is working on treatments for dementia, depression, and migraine headaches. Subsidiary NeoOncoRx focuses on developing treatments for cancer, while its NeoGene Technologies unit researches functional genomics.

 COMPETITION
Centaur Pharmaceuticals, Inc. (dossier)
Guilford Pharmaceuticals Inc. (GLFD)
Regeneron Pharmaceuticals, Inc. (REGN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 61
Revenue per employee: $1,639.34

 KEY PEOPLE
• Alvin J. Glasky
    CEO
• Samuel Gulko
    CFO

 CONTACT INFO
157 Technology Dr.
Irvine, CA 92618
US
Phone: 949-788-6700
Fax: 949-788-6706
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001